Oxalic Acid

Oxalic Acid

SCHEMBL7448579

COc1ccc2c(c1)c(CCN)c(C)n2S(=O)(=O)c1ccccc1.O=C(O)C(=O)O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 8/20 0.71
PTGDR2 Q9Y5Y4 4/20 0.56
PTGDR Q13258 3/20 0.56
PLA2G2A P14555 5/20 0.50
PLA2G4A P47712 1/20 0.47
HTR1A P08908 1/20 0.45
DRD2 P14416 1/20 0.45
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR1E P28566 1/20 0.45
HTR1F P30939 1/20 0.45
HTR7 P34969 1/20 0.45
DRD3 P35462 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45
HIF1A Q16665 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5498898 0.83 HTR6 (1.00) HTR6PTGDR2PTGDRHTR1ADRD2
SCHEMBL7448584 0.81 HTR6 (0.60) HTR6PTGDR2PTGDRPLA2G2APLA2G4A
SCHEMBL3557075 0.79 HTR6 (0.64) HTR6PTGDR2PTGDRHTR1ADRD2
SCHEMBL2007315 0.76 PTGDR2 (0.74) HTR6PTGDR2PTGDRPLA2G2ALMNA
SCHEMBL18239754 0.76 HTR6 (0.57) HTR6PTGDR2PTGDRCYP1A2CYP2D6
SCHEMBL18239786 0.74 HTR6 (0.56) HTR6PTGDR2PTGDR
SCHEMBL18222517 0.74 HTR6 (0.56) HTR6PTGDR2PTGDR
SCHEMBL4374944 0.74 HTR6 (0.60) HTR6PTGDR2PTGDR
SCHEMBL29586628 0.73 HTR6 (0.47) HTR6PTGDR2PTGDRHTR1AHTR1D
SCHEMBL13228926 0.73 PTGS2 (0.65) HTR6PTGDR2PTGDRPLA2G2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187805-B1 TREATING CONDITION FOR WHICH SELECTIVE AGONISM OR ANTAGONISM OF 5-HT-6 RECEPTORS IS INDICATED BY ADMINISTERING COMPOUNDS SUCH AS N,N-DIMETHYL 2-(1-(BENZENESULPHONYL)-5-METHOXY-1H-INDOL-3-YL)ETHYLAMINE MERCK SHARP & DOHME LTD. (GB) 2001-02-13 US disclosed